Noxopharm Ltd.ASX: NOX

Cleansing Statement

· Issued by Noxopharm Ltd. via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Noxopharm Ltd. has issued a Cleansing Statement regarding the issuance of new shares. The company issued new shares in lieu of Directors’ Fees, as approved by shareholders at the recent Annual General Meeting. This notice is provided under the Corporations Act, confirming compliance with relevant provisions. Noxopharm assures that there is no excluded information that needs to be disclosed at this time.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Cleansing Statement Sydney, 20 November 2026: Australian clinical-stage biotechnology company Noxopharm Limited (ASX:NOX) (Noxopharm or the Company) has today issued 1,240,351 new fully paid shares in lieu of Directors’ Fees, as approved by the shareholders of the Company at the 2026 Annual...

Noxopharm Ltd. on 6ix

Earlier from Noxopharm

Later from Noxopharm

All Noxopharm news releases